Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/32901
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | STESSEL, Bjorn | - |
dc.contributor.author | Vancuchelen, Charlotte | - |
dc.contributor.author | BRUCKERS, Liesbeth | - |
dc.contributor.author | Geebelen, Laurien | - |
dc.contributor.author | CALLEBAUT, Ina | - |
dc.contributor.author | VANDENBRANDE, Jeroen | - |
dc.contributor.author | Pallens, Ben | - |
dc.contributor.author | Van Tornout, Michiel | - |
dc.contributor.author | Ory, Jean-Paul | - |
dc.contributor.author | van Halem, Karlijn | - |
dc.contributor.author | MESSIAEN, Peter | - |
dc.contributor.author | HERBOTS, Lieven | - |
dc.contributor.author | Ramaekers, Dirk | - |
dc.contributor.author | Dubois, Jasperina | - |
dc.date.accessioned | 2020-12-14T09:53:50Z | - |
dc.date.available | 2020-12-14T09:53:50Z | - |
dc.date.issued | 2020 | - |
dc.date.submitted | 2020-11-24T12:51:43Z | - |
dc.identifier.citation | Thrombosis Research, 194 , p. 209 -215 | - |
dc.identifier.issn | 0049-3848 | - |
dc.identifier.uri | http://hdl.handle.net/1942/32901 | - |
dc.description.abstract | Introduction: An individualised thromboprophylaxis was implemented in critically ill patients suffering from coronavirus disease 2019 (COVID-19) pneumonia to reduce mortality and improve clinical outcome. The aim of this study was to evaluate the effect of this intervention on clinical outcome. Methods: In this mono-centric, controlled, before-after study, all consecutive adult patients with confirmed COVID-19 pneumonia admitted to ICU from March 13th to April 20th 2020 were included. A thromboprophylaxis protocol, including augmented LMWH dosing, individually tailored with anti-Xa measurements and twice-weekly ultrasonography screening for DVT, was implemented on March 31th 2020. Primary endpoint is one-month mortality. Secondary outcomes include two-week and three-week mortality, the incidence of VTE, acute kidney injury and continuous renal replacement therapy (CRRT). Multiple regression modelling was used to correct for differences between the two groups. Results: 46 patients were included in the before group, 26 patients in the after group. One month mortality decreased from 39.13% to 3.85% (p < 0.001). After correction for confounding variables, one-month mortality was significantly higher in the before group (p = 0.02, OR 8.86 (1.46, 53.75)). The cumulative incidence of VTE and CRRT was respectively 41% and 30.4% in the before group and dropped to 15% (p = 0.03) and 3.8% (p = 0.01), respectively. After correction for confounding variables, risk of VTE (p = 0.03, 6.01 (1.13, 32.12)) and CRRT (p = 0.02, OR 19.21 (1.44, 255.86)) remained significantly higher in the before group. Conclusion: Mortality, cumulative risk of VTE and need for CRRT may be significantly reduced in COVID-19 patients by implementation of a more aggressive thromboprophylaxis protocol. Future research should focus on confirmation of these results in a randomized design and on uncovering the mechanisms underlying these observations. . | - |
dc.description.sponsorship | This study is part of the Limburg Clinical Research Program (LCRP) UHasselt-ZOL-Jessa, supported by the foundation Limburg Sterk Merk, province of Limburg, Flemish government, Hasselt University, Ziekenhuis Oost-Limburg and Jessa Hospital. | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.rights | 2020 Elsevier Ltd. All rights reserved | - |
dc.subject.other | COVID-19 | - |
dc.subject.other | Thromboprophylaxis | - |
dc.subject.other | Venous thromboembolism | - |
dc.subject.other | Mortality | - |
dc.subject.other | Continuous renal replacement therapy | - |
dc.title | Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 215 | - |
dc.identifier.spage | 209 | - |
dc.identifier.volume | 194 | - |
local.format.pages | 7 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Stessel, B (corresponding author), Jessa Hosp Hasselt, Dept Intens Care & Anesthesiol, Virga Jesse Campus,Stadsomvaart 11, B-3500 Hasselt, Belgium. | - |
dc.description.notes | bjorn.stessel@jessazh.be | - |
dc.description.other | Stessel, B (corresponding author), Jessa Hosp Hasselt, Dept Intens Care & Anesthesiol, Virga Jesse Campus,Stadsomvaart 11, B-3500 Hasselt, Belgium. bjorn.stessel@jessazh.be | - |
local.publisher.place | THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1016/j.thromres.2020.07.038 | - |
dc.identifier.pmid | 32788120 | - |
dc.identifier.isi | WOS:000568490100037 | - |
dc.contributor.orcid | Callebaut, Ina/0000-0002-6666-6783 | - |
dc.identifier.eissn | 1879-2472 | - |
local.provider.type | wosris | - |
local.uhasselt.uhpub | yes | - |
local.description.affiliation | [Stessel, Bjorn; Vancuchelen, Charlotte; Geebelen, Laurien; Callebaut, Ina; Vandenbrande, Jeroen; Pallens, Ben; Van Tornout, Michiel; Ory, Jean-Paul; Dubois, Jasperina] Jessa Hosp, Dept Intens Care & Anesthesiol, Hasselt, Belgium. | - |
local.description.affiliation | [Stessel, Bjorn; Callebaut, Ina; Messiaen, Peter] UHasselt, Fac Med & Life Sci, LCRC, B-3590 Diepenbeek, Belgium. | - |
local.description.affiliation | [Geebelen, Laurien] Hasselt Univ, Data Sci Inst, I BioStat, Martelarenlaan 42, B-3500 Hasselt, Belgium. | - |
local.description.affiliation | [van Halem, Karlijn; Messiaen, Peter] Jessa Hosp, Dept Infect Dis & Immun, Hasselt, Belgium. | - |
local.description.affiliation | [Herbots, Lieven] Jessa Hosp, Dept Cardiol, Hasselt, Belgium. | - |
local.description.affiliation | [Herbots, Lieven] Jessa Hosp, Coronary Care Unit, Hasselt, Belgium. | - |
local.description.affiliation | [Ramaekers, Dirk] Jessa Hosp, Hasselt, Belgium. | - |
local.description.affiliation | [Ramaekers, Dirk] Univ Leuven, Leuven Inst Healthcare Policy LIHP, Leuven, Belgium. | - |
local.uhasselt.international | no | - |
item.contributor | STESSEL, Bjorn | - |
item.contributor | Vancuchelen, Charlotte | - |
item.contributor | BRUCKERS, Liesbeth | - |
item.contributor | Geebelen, Laurien | - |
item.contributor | CALLEBAUT, Ina | - |
item.contributor | VANDENBRANDE, Jeroen | - |
item.contributor | Pallens, Ben | - |
item.contributor | Van Tornout, Michiel | - |
item.contributor | Ory, Jean-Paul | - |
item.contributor | van Halem, Karlijn | - |
item.contributor | MESSIAEN, Peter | - |
item.contributor | HERBOTS, Lieven | - |
item.contributor | Ramaekers, Dirk | - |
item.contributor | Dubois, Jasperina | - |
item.fullcitation | STESSEL, Bjorn; Vancuchelen, Charlotte; BRUCKERS, Liesbeth; Geebelen, Laurien; CALLEBAUT, Ina; VANDENBRANDE, Jeroen; Pallens, Ben; Van Tornout, Michiel; Ory, Jean-Paul; van Halem, Karlijn; MESSIAEN, Peter; HERBOTS, Lieven; Ramaekers, Dirk & Dubois, Jasperina (2020) Impact of implementation of an individualised thromboprophylaxis protocol in critically ill ICU patients with COVID-19: A longitudinal controlled before-after study. In: Thrombosis Research, 194 , p. 209 -215. | - |
item.accessRights | Open Access | - |
item.fulltext | With Fulltext | - |
item.validation | ecoom 2021 | - |
crisitem.journal.issn | 0049-3848 | - |
crisitem.journal.eissn | 1879-2472 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0049384820303297-main.pdf | Published version | 558.17 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.